Thackray Helen M. bought BCRX
May 14, 2024 · Form 4 insider transaction
Thackray Helen M. bought 30,000 shares of BioCryst Pharmaceuticals, Inc. at $5.86 per share, a transaction worth $175.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$5.86
Total value
$175.8K
InsiderThackray Helen M.
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 14, 2024
Filing dateMay 15, 2024
Shares owned after272,139
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.84 to $5.86. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.